$XXII 3 SEC Filings

Filed On	Filing
05 Aug 2025	Form 3: Keys David N, Director No securities owned
10 Oct 2024	Form 3: Marion Arvil S., VP of Mfg. Operations No securities owned
16 Sep 2024	Form 3: Manfredonia Robert P, EVP of Sales and Marketing No securities owned
29 Apr 2024	Form 3: Otto Daniel A, Chief Financial Officer Holds 427 shares of Common Stock
29 Apr 2024	Form 3: Staffeldt Jonathan, VP and Deputy General Counsel Holds 112 shares of Common Stock
08 Dec 2023	Form 3: Firestone Lawrence, Director No securities owned
27 Jul 2023	Form 3: Arno Andrew, Director No securities owned
03 Mar 2023	Form 3: Ferola Peter, Chief Legal Officer No securities owned
17 Nov 2022	Form 3: Miller John J, President, Tobacco Holds 75,000 shares of Common Stock
12 Sep 2022	Form 3: Salhany Lucille S, Director No securities owned
03 Aug 2022	Form 3: Kinsman Robert Hugh, Chief Financial Officer Holds 52,327 shares of Common Stock
19 Nov 2021	Form 3: Fitzgerald Richard F, Chief Financial Officer No securities owned
26 Aug 2021	Form 3: Johnson Anthony L., Director Holds 0 shares of Common Stock
09 Jul 2021	Form 3: 22nd Century Group, Inc., 10% owner · Panacea Life Sciences Holdings Inc Holds 91,016,026 shares of Common Stock
22 Sep 2020	Form 3: Koganov Michael, Director No securities owned
23 Jun 2020	Form 3: Mish James A, Chief Executive Officer No securities owned
05 Jun 2020	Form 3: Franzino John, CFO Holds 100,000 shares of Restricted Common Stock Units
16 Jan 2020	Form 3: O'brien Roger D, Director No securities owned
04 Dec 2019	Form 3: Jentsch Andrea S, Chief Financial Officer Holds 50,000 shares of Common Stock
09 Aug 2019	Form 3: Fleet Clifford B, Director No securities owned

Comments